查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1545580

大腸桿菌檢測的全球市場

E. Coli Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球大腸桿菌檢測市場將達到 32 億美元

全球大腸桿菌檢測市場預計 2023 年為 23 億美元，預計到 2030 年將達到 32 億美元，2023 年至 2030 年複合年成長率為 5.1%。環境測試最終用途是本報告分析的細分市場之一，預計複合年成長率為 5.7%，到分析期結束時將達到 20 億美元。在分析期間，臨床測試最終用途細分市場的複合年成長率預計為 4.2%。

美國市場預估為6.114億美元，中國預期複合年成長率為8.6%

預計 2023 年美國大腸桿菌檢測市場規模將達 6.114 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到7.037億美元，2023-2030年分析期間複合年成長率為8.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 1.6% 和 5.6%。在歐洲，德國的複合年成長率預計為 2.7%。

全球大腸桿菌檢測市場 - 主要趨勢和促進因素總結

什麼是大腸桿菌測試？

大腸桿菌檢測是臨床和環境環境中用於檢測大腸桿菌是否存在的重要程序，可顯示糞便污染和有害病原體的潛在存在。此測試對於預防食物中毒爆發和確保水質至關重要。雖然大腸桿菌通常是無害的，但也有一些致病類型，例如大腸桿菌 O157，它會導致嚴重腹痛、腹瀉和嘔吐。快速且準確地檢測這些細菌對於有效控制和治療感染疾病的醫療保健以及預防受污染的食品和水供應引起的廣泛爆發至關重要。

大腸桿菌測試是如何演變的？

支持大腸桿菌測試的調查方法已經從傳統的基於培養的測試顯著進步到更快速的分子技術。傳統方法雖然高度可靠，但需要幾天時間才能得出結果，而聚合酵素鏈鎖反應(PCR) 和酵素結合免疫吸附檢測法(ELISA) 等現代分子技術可以在數小時內獲得結果。這些治療方法進展大大減少了醫療和食品安全專業人員識別潛在疫情和實施必要控制所需的時間，從而降低了公共衛生風險並改善了食品生產和水處理設施的安全通訊協定。

哪些技術將塑造大腸桿菌測試的未來？

生物技術和微生物學的新技術正在進一步提高大腸桿菌檢測的效率和準確性。基於 CRISPR 的生物感測器和次世代定序(NGS) 等創新正在為快速鑑定細菌菌株設定新標準。這些技術不僅減少了檢測時間，還提供了識別抗生素抗藥性的能力，從而增強了治療和介入的策略應用。此外，人工智慧 (AI) 在診斷過程中的整合開始發揮關鍵作用，演算法可預測疫情爆發並自動監測各種環境中的大腸桿菌水平，支持積極的公共衛生措施。

大腸桿菌檢測市場擴大的驅動力是什麼？

大腸桿菌檢測市場的成長是由多種因素推動的，這些因素反映了多個行業對快速、可靠的檢測解決方案不斷成長的需求。公眾健康意識以及有關食品安全和水質的嚴格監管標準是主要的成長動力。隨著全球食品供應鏈變得更加複雜，有效微生物監測的需求不斷增加，因此需要強力的測試通訊協定來確保消費者安全。提供更快、更準確測試選項的技術進步也為市場擴張做出了重大貢獻。此外，健康意識的增強和大腸桿菌相關疾病發生率的增加正迫使食品和飲料行業和水資源管理務部門投資於更好的測試和檢測系統。這些動態證實，技術創新、監管要求以及公共安全和健康的迫切需求正在推動市場發展。

受訪企業範例（共14家）

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP11661

Global E. Coli Testing Market to Reach US$3.2 Billion by 2030

The global market for E. Coli Testing estimated at US$2.3 Billion in the year 2023, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Environmental Testing End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Clinical Testing End-Use segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$611.4 Million While China is Forecast to Grow at 8.6% CAGR

The E. Coli Testing market in the U.S. is estimated at US$611.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$703.7 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global E. Coli Testing Market - Key Trends and Drivers Summarized

What Is E. Coli Testing and Why Is It Crucial?

E.coli testing is a critical procedure used in both clinical and environmental settings to detect the presence of Escherichia coli bacteria, which can indicate fecal contamination and the potential presence of harmful pathogens. This testing is essential in preventing outbreaks of foodborne illnesses and ensuring water quality. E. coli strains, while often harmless, can include virulent types such as E. coli O157, which cause severe abdominal cramps, diarrhea, and vomiting. Rapid and accurate detection of these bacteria is crucial in healthcare to manage and treat infections effectively and in public health to prevent widespread outbreaks from contaminated food or water supplies.

How Has E. Coli Testing Evolved Over the Years?

The methodology behind E. coli testing has seen substantial advancements, moving from traditional culture-based tests to more rapid molecular techniques. Traditional methods, while reliable, require several days to yield results, whereas modern molecular techniques, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA), can provide results within hours. These advancements significantly reduce the time health professionals and food safety experts need to identify potential outbreaks and implement necessary controls, thereby minimizing public health risks and improving safety protocols in food production and water treatment facilities.

What Technologies Are Shaping the Future of E. Coli Testing?

Emerging technologies in biotechnology and microbiology are further refining the efficiency and accuracy of E. coli testing. Innovations such as CRISPR-based biosensors and next-generation sequencing (NGS) are setting new standards in the rapid identification of bacterial strains. These technologies offer not only faster detection times but also the ability to identify antibiotic resistance profiles, enhancing the strategic application of treatments and interventions. Additionally, the integration of artificial intelligence (AI) in diagnostic processes is beginning to play a pivotal role, with algorithms that can predict outbreaks and automate the monitoring of E. coli levels in various environments, thus supporting proactive public health measures.

What Drives the Expansion of the E. Coli Testing Market?

The growth in the E. coli testing market is driven by several factors, reflecting an increased demand for fast, reliable testing solutions across multiple sectors. Public health awareness and stringent regulatory standards concerning food safety and water quality are primary growth drivers. As global food supply chains become more complex, the need for effective microbial monitoring escalates, necessitating robust testing protocols to ensure consumer safety. Technological advancements that offer quicker, more accurate testing options are also major contributors to market expansion. Furthermore, the rise in health-conscious consumer behavior, coupled with an increase in outbreaks of E. coli-related illnesses, compels food and beverage industries and water management authorities to invest in better testing and detection systems. These dynamics underscore a market driven by innovation, regulatory demands, and the essential need for public safety and health.

Select Competitors (Total 14 Featured) -

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • E. Coli Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Foodborne Illnesses Drives Demand for E. Coli Testing Solutions
    • Advances in Molecular Diagnostic Technologies Propel Growth in E. Coli Testing Market
    • Increasing Focus on Food Safety and Regulatory Compliance Strengthens Business Case for E. Coli Testing
    • Expansion of E. Coli Testing in Water and Environmental Monitoring Spurs Demand for Rapid Detection Solutions
    • Growing Applications of E. Coli Testing in Agriculture and Animal Husbandry Drive Market Expansion
    • Rising Demand for E. Coli Testing in Water Treatment and Quality Control Expands Addressable Market
    • Growing Emphasis on Consumer Awareness and Education Drives Adoption of E. Coli Testing in Retail and Food Service
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Environmental Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World E. Coli Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • JAPAN
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • CHINA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • EUROPE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • FRANCE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • GERMANY
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • INDIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • AFRICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030

IV. COMPETITION